Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 4285 to 4294 of 4294 entries
Sorted by: Best Match Show Resources per page
Conversion of underwater endoscopic mucosal resection to gel immersion for the resection of a superficial non-ampullary duodenal epithelial tumor.

Endoscopy international open

Tashima T, Nakano Y, Kawasaki T, Jinushi R, Fujita A, Tanisaka Y, Ryozawa S.
PMID: 34917464
Endosc Int Open. 2021 Dec 14;9(12):E1924-E1925. doi: 10.1055/a-1633-3303. eCollection 2021 Dec.

No abstract available.

Cite
Tashima T, Nakano Y, Kawasaki T, et al. Conversion of underwater endoscopic mucosal resection to gel immersion for the resection of a superficial non-ampullary duodenal epithelial tumor. Endosc Int Open. 2021;9(12):E1924-E1925doi: 10.1055/a-1633-3303.
Tashima, T., Nakano, Y., Kawasaki, T., Jinushi, R., Fujita, A., Tanisaka, Y., & Ryozawa, S. (2021). Conversion of underwater endoscopic mucosal resection to gel immersion for the resection of a superficial non-ampullary duodenal epithelial tumor. Endoscopy international open, 9(12), E1924-E1925. https://doi.org/10.1055/a-1633-3303
Tashima, Tomoaki, et al. "Conversion of underwater endoscopic mucosal resection to gel immersion for the resection of a superficial non-ampullary duodenal epithelial tumor." Endoscopy international open vol. 9,12 (2021): E1924-E1925. doi: https://doi.org/10.1055/a-1633-3303
Tashima T, Nakano Y, Kawasaki T, Jinushi R, Fujita A, Tanisaka Y, Ryozawa S. Conversion of underwater endoscopic mucosal resection to gel immersion for the resection of a superficial non-ampullary duodenal epithelial tumor. Endosc Int Open. 2021 Dec 14;9(12):E1924-E1925. doi: 10.1055/a-1633-3303. eCollection 2021 Dec. PMID: 34917464; PMCID: PMC8671000.
Copy Download .nbib Format: NLM
Development of receptive vocabulary and verbal intelligence in Japanese children with unilateral hearing loss.

Auris, nasus, larynx

Takeyama T, Shimada A, Sakamoto Y, Aoki T, Kondo E, Nakano S, Fukuda J, Azuma T, Sato G, Okamoto H, Kitamura Y, Udaka J, Takeda N.
PMID: 34511300
Auris Nasus Larynx. 2021 Sep 09; doi: 10.1016/j.anl.2021.08.002. Epub 2021 Sep 09.

OBJECTIVE: In the past, it was believed that unilateral hearing loss has a minimal impact on the speech and language development in children. However, several studies have suggested that some school-age children with unilateral hearing loss have learning impairments...

Cite
Takeyama T, Shimada A, Sakamoto Y, et al. Development of receptive vocabulary and verbal intelligence in Japanese children with unilateral hearing loss. Auris Nasus Larynx. 2021;doi: 10.1016/j.anl.2021.08.002.
Takeyama, T., Shimada, A., Sakamoto, Y., Aoki, T., Kondo, E., Nakano, S., Fukuda, J., Azuma, T., Sato, G., Okamoto, H., Kitamura, Y., Udaka, J., & Takeda, N. (2021). Development of receptive vocabulary and verbal intelligence in Japanese children with unilateral hearing loss. Auris, nasus, larynx, . https://doi.org/10.1016/j.anl.2021.08.002
Takeyama, Takaaki, et al. "Development of receptive vocabulary and verbal intelligence in Japanese children with unilateral hearing loss." Auris, nasus, larynx vol. (2021). doi: https://doi.org/10.1016/j.anl.2021.08.002
Takeyama T, Shimada A, Sakamoto Y, Aoki T, Kondo E, Nakano S, Fukuda J, Azuma T, Sato G, Okamoto H, Kitamura Y, Udaka J, Takeda N. Development of receptive vocabulary and verbal intelligence in Japanese children with unilateral hearing loss. Auris Nasus Larynx. 2021 Sep 09; doi: 10.1016/j.anl.2021.08.002. Epub 2021 Sep 09. PMID: 34511300.
Copy Download .nbib Format: NLM
Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders in patients treated with methotrexate: a retrospective, multi-center descriptive study.

Modern rheumatology

Nakano K, Tanaka Y, Saito K, Kaneko Y, Saito S, Tanaka M, Saito R, Fujii T, Kuramoto N, Sugimoto N, Takada H, Harigai M, Sasaki S, Suzuki Y.
PMID: 34919717
Mod Rheumatol. 2020 Dec 07; doi: 10.1080/14397595.2020.1847775. Epub 2020 Dec 07.

OBJECTIVES: To identify the optimal treatment for rheumatoid arthritis (RA) after the regression of lymphoproliferative disorders (LPDs).METHODS: The subjects were 232 patients with RA who developed LPD between 2000 and 2017 at seven hospitals participating in the LPD-WG study....

Cite
Nakano K, Tanaka Y, Saito K, et al. Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders in patients treated with methotrexate: a retrospective, multi-center descriptive study. Mod Rheumatol. 2020;doi: 10.1080/14397595.2020.1847775.
Nakano, K., Tanaka, Y., Saito, K., Kaneko, Y., Saito, S., Tanaka, M., Saito, R., Fujii, T., Kuramoto, N., Sugimoto, N., Takada, H., Harigai, M., Sasaki, S., & Suzuki, Y. (2020). Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders in patients treated with methotrexate: a retrospective, multi-center descriptive study. Modern rheumatology, . https://doi.org/10.1080/14397595.2020.1847775
Nakano, Kazuhisa, et al. "Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders in patients treated with methotrexate: a retrospective, multi-center descriptive study." Modern rheumatology vol. (2020). doi: https://doi.org/10.1080/14397595.2020.1847775
Nakano K, Tanaka Y, Saito K, Kaneko Y, Saito S, Tanaka M, Saito R, Fujii T, Kuramoto N, Sugimoto N, Takada H, Harigai M, Sasaki S, Suzuki Y. Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders in patients treated with methotrexate: a retrospective, multi-center descriptive study. Mod Rheumatol. 2020 Dec 07; doi: 10.1080/14397595.2020.1847775. Epub 2020 Dec 07. PMID: 34919717.
Copy Download .nbib Format: NLM
Multimolecular-Targeted Agents for Intermediate-Stage Hepatocellular Carcinoma Influence Time to Stage Progression and Overall Survival.

Oncology

Shimose S, Iwamoto H, Tanaka M, Niizeki T, Shirono T, Kajiwara A, Noda Y, Kamachi N, Okamura S, Nakano M, Kuromatsu R, Kawaguchi T, Koga H, Torimura T.
PMID: 34518483
Oncology. 2021;99(12):756-765. doi: 10.1159/000518612. Epub 2021 Sep 08.

Background & Aims: Intermediate hepatocellular carcinoma (HCC) treatment has become complicated due to the development of various molecular-targeted agents (MTAs). We aimed to determine whether the administration of MTAs in patients with intermediate-stage HCC contributed to the prevention of...

Cite
Shimose S, Iwamoto H, Tanaka M, et al. Multimolecular-Targeted Agents for Intermediate-Stage Hepatocellular Carcinoma Influence Time to Stage Progression and Overall Survival. Oncology. 2021;99(12):756-765doi: 10.1159/000518612.
Shimose, S., Iwamoto, H., Tanaka, M., Niizeki, T., Shirono, T., Kajiwara, A., Noda, Y., Kamachi, N., Okamura, S., Nakano, M., Kuromatsu, R., Kawaguchi, T., Koga, H., & Torimura, T. (2021). Multimolecular-Targeted Agents for Intermediate-Stage Hepatocellular Carcinoma Influence Time to Stage Progression and Overall Survival. Oncology, 99(12), 756-765. https://doi.org/10.1159/000518612
Shimose, Shigeo, et al. "Multimolecular-Targeted Agents for Intermediate-Stage Hepatocellular Carcinoma Influence Time to Stage Progression and Overall Survival." Oncology vol. 99,12 (2021): 756-765. doi: https://doi.org/10.1159/000518612
Shimose S, Iwamoto H, Tanaka M, Niizeki T, Shirono T, Kajiwara A, Noda Y, Kamachi N, Okamura S, Nakano M, Kuromatsu R, Kawaguchi T, Koga H, Torimura T. Multimolecular-Targeted Agents for Intermediate-Stage Hepatocellular Carcinoma Influence Time to Stage Progression and Overall Survival. Oncology. 2021;99(12):756-765. doi: 10.1159/000518612. Epub 2021 Sep 08. PMID: 34518483.
Copy Download .nbib Format: NLM
Long Carbon-Carbon Bonding beyond 2 Å in Tris(9-fluorenylidene)methane.

Journal of the American Chemical Society

Kubo T, Suga Y, Hashizume D, Suzuki H, Miyamoto T, Okamoto H, Kishi R, Nakano M.
PMID: 34459597
J Am Chem Soc. 2021 Sep 08;143(35):14360-14366. doi: 10.1021/jacs.1c07431. Epub 2021 Aug 30.

We report on our investigation of C-C bonding longer than 2.0 Å, which can be realized by perpendicularly facing two fluorenyl rings in the title compound. A small orbital overlap between the distantly positioned carbon atoms is observed as...

Cite
Kubo T, Suga Y, Hashizume D, et al. Long Carbon-Carbon Bonding beyond 2 Å in Tris(9-fluorenylidene)methane. J Am Chem Soc. 2021;143(35):14360-14366doi: 10.1021/jacs.1c07431.
Kubo, T., Suga, Y., Hashizume, D., Suzuki, H., Miyamoto, T., Okamoto, H., Kishi, R., & Nakano, M. (2021). Long Carbon-Carbon Bonding beyond 2 Å in Tris(9-fluorenylidene)methane. Journal of the American Chemical Society, 143(35), 14360-14366. https://doi.org/10.1021/jacs.1c07431
Kubo, Takashi, et al. "Long Carbon-Carbon Bonding beyond 2 Å in Tris(9-fluorenylidene)methane." Journal of the American Chemical Society vol. 143,35 (2021): 14360-14366. doi: https://doi.org/10.1021/jacs.1c07431
Kubo T, Suga Y, Hashizume D, Suzuki H, Miyamoto T, Okamoto H, Kishi R, Nakano M. Long Carbon-Carbon Bonding beyond 2 Å in Tris(9-fluorenylidene)methane. J Am Chem Soc. 2021 Sep 08;143(35):14360-14366. doi: 10.1021/jacs.1c07431. Epub 2021 Aug 30. PMID: 34459597.
Copy Download .nbib Format: NLM
Thermoreversible gelation of isotactic-rich poly(N-isopropylacrylamide) in water.

The Journal of chemical physics

Nakano S, Ogiso T, Kita R, Shinyashiki N, Yagihara S, Yoneyama M, Katsumoto Y.
PMID: 21950883
J Chem Phys. 2011 Sep 21;135(11):114903. doi: 10.1063/1.3637943.

We report the experimentally determined phase diagram for an aqueous solution of isotactic-rich poly(N-isopropylacrylamide) (PNiPAM) composed of the sol-gel transition curve and the cloud-point curve. The meso diad content of isotactic-rich PNiPAM is 64%, and it is soluble in...

Cite
Nakano S, Ogiso T, Kita R, et al. Thermoreversible gelation of isotactic-rich poly(N-isopropylacrylamide) in water. J Chem Phys. 2011;135(11):114903doi: 10.1063/1.3637943.
Nakano, S., Ogiso, T., Kita, R., Shinyashiki, N., Yagihara, S., Yoneyama, M., & Katsumoto, Y. (2011). Thermoreversible gelation of isotactic-rich poly(N-isopropylacrylamide) in water. The Journal of chemical physics, 135(11), 114903. https://doi.org/10.1063/1.3637943
Nakano, Shinya, et al. "Thermoreversible gelation of isotactic-rich poly(N-isopropylacrylamide) in water." The Journal of chemical physics vol. 135,11 (2011): 114903. doi: https://doi.org/10.1063/1.3637943
Nakano S, Ogiso T, Kita R, Shinyashiki N, Yagihara S, Yoneyama M, Katsumoto Y. Thermoreversible gelation of isotactic-rich poly(N-isopropylacrylamide) in water. J Chem Phys. 2011 Sep 21;135(11):114903. doi: 10.1063/1.3637943. PMID: 21950883.
Copy Download .nbib Format: NLM
Genotype-Phenotype Correlation in .

Kidney international reports

Nagano C, Takaoka Y, Kamei K, Hamada R, Ichikawa D, Tanaka K, Aoto Y, Ishiko S, Rossanti R, Sakakibara N, Okada E, Horinouchi T, Yamamura T, Tsuji Y, Noguchi Y, Ishimori S, Nagase H, Ninchoji T, Iijima K, Nozu K.
PMID: 34386660
Kidney Int Rep. 2021 May 19;6(8):2114-2121. doi: 10.1016/j.ekir.2021.05.009. eCollection 2021 Aug.

METHODS: We conducted a systematic review of 174 cases with RESULTS: The median age of developing ESKD was 1.17 years. A comparative study was conducted among three CONCLUSION: Not only the DNA-binding site but also C2H2 zinc finger structure...

Cite
Nagano C, Takaoka Y, Kamei K, et al. Genotype-Phenotype Correlation in . Kidney Int Rep. 2021;6(8):2114-2121doi: 10.1016/j.ekir.2021.05.009.
Nagano, C., Takaoka, Y., Kamei, K., Hamada, R., Ichikawa, D., Tanaka, K., Aoto, Y., Ishiko, S., Rossanti, R., Sakakibara, N., Okada, E., Horinouchi, T., Yamamura, T., Tsuji, Y., Noguchi, Y., Ishimori, S., Nagase, H., Ninchoji, T., Iijima, K., & Nozu, K. (2021). Genotype-Phenotype Correlation in . Kidney international reports, 6(8), 2114-2121. https://doi.org/10.1016/j.ekir.2021.05.009
Nagano, China, et al. "Genotype-Phenotype Correlation in ." Kidney international reports vol. 6,8 (2021): 2114-2121. doi: https://doi.org/10.1016/j.ekir.2021.05.009
Nagano C, Takaoka Y, Kamei K, Hamada R, Ichikawa D, Tanaka K, Aoto Y, Ishiko S, Rossanti R, Sakakibara N, Okada E, Horinouchi T, Yamamura T, Tsuji Y, Noguchi Y, Ishimori S, Nagase H, Ninchoji T, Iijima K, Nozu K. Genotype-Phenotype Correlation in . Kidney Int Rep. 2021 May 19;6(8):2114-2121. doi: 10.1016/j.ekir.2021.05.009. eCollection 2021 Aug. PMID: 34386660; PMCID: PMC8343804.
Copy Download .nbib Format: NLM
Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.

mBio

Matsui M, Fukunishi S, Nakano T, Ueno T, Higuchi K, Asai A.
PMID: 34225483
mBio. 2021 Aug 31;12(4):e0115521. doi: 10.1128/mBio.01155-21. Epub 2021 Jul 06.

Nonalcoholic fatty liver disease (NAFLD), characterized by excessive fat deposition in the liver unrelated to alcohol consumption, is highly prevalent worldwide. However, effective therapeutic agents approved for NAFLD treatment are lacking. An ileal bile acid transporter inhibitor (IBATi), which...

Cite
Matsui M, Fukunishi S, Nakano T, et al. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice. mBio. 2021;12(4):e0115521doi: 10.1128/mBio.01155-21.
Matsui, M., Fukunishi, S., Nakano, T., Ueno, T., Higuchi, K., & Asai, A. (2021). Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice. mBio, 12(4), e0115521. https://doi.org/10.1128/mBio.01155-21
Matsui, Masahiro, et al. "Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice." mBio vol. 12,4 (2021): e0115521. doi: https://doi.org/10.1128/mBio.01155-21
Matsui M, Fukunishi S, Nakano T, Ueno T, Higuchi K, Asai A. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice. mBio. 2021 Aug 31;12(4):e0115521. doi: 10.1128/mBio.01155-21. Epub 2021 Jul 06. PMID: 34225483; PMCID: PMC8406289.
Copy Download .nbib Format: NLM
Phospho-Smad3 signaling is predictive biomarker for hepatocellular carcinoma risk assessment in primary biliary cholangitis patients.

Frontiers in bioscience (Landmark edition)

Nakamura N, Yoshida K, Tsuda R, Murata M, Yamaguchi T, Suwa K, Ichimura M, Tsuneyama K, Matsuzaki K, Nakano T, Hirohara J, Seki T, Okazaki K, Gershwin ME, Naganuma M.
PMID: 34994163
Front Biosci (Landmark Ed). 2021 Dec 30;26(12):1480-1492. doi: 10.52586/5042.

INTRODUCTION: Patients with primary biliary cholangitis (PBC) are at increased risk for development of hepatocellular carcinoma (HCC), particularly in the presence of comorbidities such as excessive alcohol consumption. Although liver fibrosis is an important risk factor for HCC development,...

Cite
Nakamura N, Yoshida K, Tsuda R, et al. Phospho-Smad3 signaling is predictive biomarker for hepatocellular carcinoma risk assessment in primary biliary cholangitis patients. Front Biosci (Landmark Ed). 2021;26(12):1480-1492doi: 10.52586/5042.
Nakamura, N., Yoshida, K., Tsuda, R., Murata, M., Yamaguchi, T., Suwa, K., Ichimura, M., Tsuneyama, K., Matsuzaki, K., Nakano, T., Hirohara, J., Seki, T., Okazaki, K., Gershwin, M. E., & Naganuma, M. (2021). Phospho-Smad3 signaling is predictive biomarker for hepatocellular carcinoma risk assessment in primary biliary cholangitis patients. Frontiers in bioscience (Landmark edition), 26(12), 1480-1492. https://doi.org/10.52586/5042
Nakamura, Naohiro, et al. "Phospho-Smad3 signaling is predictive biomarker for hepatocellular carcinoma risk assessment in primary biliary cholangitis patients." Frontiers in bioscience (Landmark edition) vol. 26,12 (2021): 1480-1492. doi: https://doi.org/10.52586/5042
Nakamura N, Yoshida K, Tsuda R, Murata M, Yamaguchi T, Suwa K, Ichimura M, Tsuneyama K, Matsuzaki K, Nakano T, Hirohara J, Seki T, Okazaki K, Gershwin ME, Naganuma M. Phospho-Smad3 signaling is predictive biomarker for hepatocellular carcinoma risk assessment in primary biliary cholangitis patients. Front Biosci (Landmark Ed). 2021 Dec 30;26(12):1480-1492. doi: 10.52586/5042. PMID: 34994163.
Copy Download .nbib Format: NLM
The effect of simple heat treatment on apatite formation on grit-blasted/acid-etched dental Ti implants already in clinical use.

Journal of biomedical materials research. Part B, Applied biomaterials

Ogura A, Yamaguchi S, Le PTM, Yamamoto K, Omori M, Inoue K, Kato-Kogoe N, Nakajima Y, Nakano H, Ueno T, Yamada T, Mori Y.
PMID: 34323348
J Biomed Mater Res B Appl Biomater. 2021 Jul 29; doi: 10.1002/jbm.b.34915. Epub 2021 Jul 29.

Grit-blasted/acid-etched titanium dental implants have a moderately roughened surface that is suitable for cell adhesion and exhibits faster osseointegration. However, the roughened surface does not always maintain stable fixation over a long period. In this study, a simple heat...

Cite
Ogura A, Yamaguchi S, Le PTM, et al. The effect of simple heat treatment on apatite formation on grit-blasted/acid-etched dental Ti implants already in clinical use. J Biomed Mater Res B Appl Biomater. 2021;doi: 10.1002/jbm.b.34915.
Ogura, A., Yamaguchi, S., Le, P. T. M., Yamamoto, K., Omori, M., Inoue, K., Kato-Kogoe, N., Nakajima, Y., Nakano, H., Ueno, T., Yamada, T., & Mori, Y. (2021). The effect of simple heat treatment on apatite formation on grit-blasted/acid-etched dental Ti implants already in clinical use. Journal of biomedical materials research. Part B, Applied biomaterials, . https://doi.org/10.1002/jbm.b.34915
Ogura, Ayano, et al. "The effect of simple heat treatment on apatite formation on grit-blasted/acid-etched dental Ti implants already in clinical use." Journal of biomedical materials research. Part B, Applied biomaterials vol. (2021). doi: https://doi.org/10.1002/jbm.b.34915
Ogura A, Yamaguchi S, Le PTM, Yamamoto K, Omori M, Inoue K, Kato-Kogoe N, Nakajima Y, Nakano H, Ueno T, Yamada T, Mori Y. The effect of simple heat treatment on apatite formation on grit-blasted/acid-etched dental Ti implants already in clinical use. J Biomed Mater Res B Appl Biomater. 2021 Jul 29; doi: 10.1002/jbm.b.34915. Epub 2021 Jul 29. PMID: 34323348.
Copy Download .nbib Format: NLM
Showing 4285 to 4294 of 4294 entries